1.835
Matinas Biopharma Holdings Inc stock is traded at $1.835, with a volume of 39,559.
It is up +7.31% in the last 24 hours and up +0.27% over the past month.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. The company enables the delivery of life-changing medicines using its lipid nano-crystal (LNC) platform technology. Its LNC delivery technology platform utilizes lipid nano-crystals which can encapsulate small molecules, oligonucleotides, vaccines, peptides, proteins and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. The company's lead anti-fungal product candidate is MAT2203, an orally-administered cochleate formulation of amphotericin B that has completed Phase II clinical trials for the prevention of invasive fungal infections due to immunosuppressive therapy in patients with acute lymphoblastic leukemia. Its product candidates also comprise MAT2501, an orally administered cochleate formulation of the broad spectrum aminoglycoside antibiotic amikacin that has completed Phase I clinical trials to treat various types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections, as well as various multidrug-resistant gram negative and intracellular bacterial infections. The company was founded in 2013 and is based in Bedminster, New Jersey.
See More
Previous Close:
$1.71
Open:
$1.75
24h Volume:
39,559
Relative Volume:
0.08
Market Cap:
$9.33M
Revenue:
-
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.3831
EPS:
-4.79
Net Cash Flow:
$-16.95M
1W Performance:
-3.52%
1M Performance:
+0.27%
6M Performance:
+239.81%
1Y Performance:
-42.30%
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Name
Matinas Biopharma Holdings Inc
Sector
Industry
Phone
908-443-1860
Address
1545 Route 206 South, Suite 302, Bedminster, NJ
Compare MTNB with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
MTNB
Matinas Biopharma Holdings Inc
|
1.835 | 9.50M | 0 | -21.13M | -16.95M | -4.79 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
May-11-21 | Downgrade | Piper Sandler | Overweight → Neutral |
Aug-26-20 | Resumed | Piper Sandler | Overweight |
Jan-27-20 | Initiated | Piper Sandler | Overweight |
Jan-24-20 | Initiated | SunTrust | Buy |
Jan-23-20 | Initiated | SunTrust | Buy |
Jan-09-20 | Initiated | Aegis Capital | Buy |
Jun-26-19 | Initiated | H.C. Wainwright | Buy |
View All
Matinas Biopharma Holdings Inc Stock (MTNB) Latest News
Matinas BioPharma Holdings Inc.’s volatility index tracking explainedJuly 2025 Final Week & Weekly Top Performers Watchlists - newser.com
Combining machine learning predictions for Matinas BioPharma Holdings Inc.July 2025 Summary & Expert Approved Trade Ideas - newser.com
Using flow based indicators on Matinas BioPharma Holdings Inc.2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Published on: 2025-10-13 08:18:05 - newser.com
Key metrics from Matinas BioPharma Holdings Inc.’s quarterly dataMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
Will Matinas BioPharma Holdings Inc. stock attract ESG investorsInsider Buying & Expert Verified Stock Movement Alerts - newser.com
Using Bollinger Bands to evaluate Matinas BioPharma Holdings Inc.Dollar Strength & Real-Time Buy Signal Alerts - newser.com
Using data tools to time your Matinas BioPharma Holdings Inc. exitWall Street Watch & Verified Momentum Stock Ideas - newser.com
Published on: 2025-10-10 08:56:38 - newser.com
Regression analysis insights on Matinas BioPharma Holdings Inc. performanceJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - newser.com
Should you hold or exit Matinas BioPharma Holdings Inc. now2025 Biggest Moves & Safe Swing Trade Setups - newser.com
Will earnings trigger a reversal in Matinas BioPharma Holdings Inc.2025 EndofYear Setup & Growth Focused Stock Reports - newser.com
Will Matinas Biopharma Holdings Inc. stock test record highs in 20252025 Retail Activity & Daily Momentum Trading Reports - newser.com
Will Matinas BioPharma Holdings Inc. stock outperform international peersQuarterly Portfolio Report & Low Risk Investment Opportunities - newser.com
Can Matinas BioPharma Holdings Inc. (6LJ0) stock beat analyst consensusJuly 2025 WrapUp & Real-Time Market Sentiment Reports - newser.com
Published on: 2025-10-09 04:30:25 - newser.com
Published on: 2025-10-09 02:57:35 - newser.com
Historical volatility pattern of Matinas BioPharma Holdings Inc. visualizedPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Is Matinas BioPharma Holdings Inc. stock a dividend growth opportunityJuly 2025 Highlights & Expert Approved Momentum Ideas - newser.com
What analysts say about Matinas BioPharma Holdings Inc stockGlobal Market Influence & Control Your Emotions With Discipline Tools - earlytimes.in
How high can Matinas BioPharma Holdings Inc. stock goChart Signals & AI Enhanced Market Trend Forecasts - newser.com
Will Matinas Biopharma Holdings Inc. stock outperform energy sector in 2025July 2025 Analyst Calls & Community Verified Swing Trade Signals - newser.com
Ranking Matinas BioPharma Holdings Inc. among high performing stocks via toolsQuarterly Portfolio Summary & Trade Opportunity Analysis - newser.com
Can Matinas BioPharma Holdings Inc. stock attract ESG capital inflows2025 Retail Activity & Weekly High Momentum Picks - newser.com
Why retail traders accumulate Matinas BioPharma Holdings Inc. (6LJ0) stockJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - newser.com
What to expect from Matinas BioPharma Holdings Inc. in the next 30 daysMarket Growth Report & Safe Capital Growth Tips - newser.com
Why institutional investors increase stakes in Matinas Biopharma Holdings Inc. stockWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Understanding Matinas BioPharma Holdings Inc.’s price movementPortfolio Update Report & Safe Capital Investment Plans - newser.com
Why millennials buy Matinas BioPharma Holdings Inc. (6LJ0) stockWeekly Trade Review & Daily Profit Maximizing Tips - newser.com
What dividend safety rating applies to Matinas BioPharma Holdings Inc. (6LJ0) stockQuarterly Trade Summary & Weekly Consistent Profit Watchlists - newser.com
Can trapped investors hope for a rebound in Matinas BioPharma Holdings Inc.Trend Reversal & AI Forecast Swing Trade Picks - newser.com
Will Matinas Biopharma Holdings Inc. stock keep high P E multiplesJuly 2025 Recap & Daily Price Action Insights - newser.com
How to build a custom watchlist for Matinas BioPharma Holdings Inc.July 2025 Catalysts & Entry and Exit Point Strategies - newser.com
Why Matinas BioPharma Holdings Inc. (6LJ0) stock gets analyst attention2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - newser.com
Is Matinas Biopharma Holdings Inc. stock undervalued historicallySell Signal & High Return Stock Watch Alerts - newser.com
Why Matinas BioPharma Holdings Inc. stock is in analyst buy zone2025 Investor Takeaways & Capital Efficiency Focused Strategies - newser.com
Matinas Biopharma Holdings Inc Stock (MTNB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):